Related Experiment Video
Updated: May 8, 2026

09:45
Co-expression of Multiple Chimeric Fluorescent Fusion Proteins in an Efficient Way in Plants
Published on: July 1, 2018
Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming
Summary
Plant molecular pharming utilizes plants to produce valuable recombinant proteins, offering a safe and sustainable alternative to traditional methods. Optimizing plant hosts and expression strategies enhances protein yield and purity for pharmaceutical applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Plant Sciences
Background:
- Plant molecular pharming offers a sustainable system for producing recombinant proteins like antibodies and vaccines.
- It presents an alternative to traditional protein extraction, addressing safety and availability concerns.
- Key factors include plant hosts, gene selection, expression vectors, and purification methods.
Purpose of the Study:
- To review recent advances and strategies in plant molecular pharming.
- To highlight the importance of plant host selection and molecular pharming elements.
- To discuss approaches for enhancing recombinant protein expression, accumulation, and purification.
Main Methods:
- Review of recent literature on plant molecular pharming strategies.
- Focus on plant host selection and expression system components.
- Analysis of upstream (promoters, codon optimization, signal sequences) and downstream (purification) processing.
Main Results:
- Plant species significantly impact recombinant protein yield.
- Expression strategies, including vector design, are crucial for high accumulation.
- Optimized promoters, codon optimization, signal sequences, and purification techniques improve protein quality and quantity.
Conclusions:
- Plant molecular pharming is a viable system for producing therapeutic proteins.
- Careful selection of plant hosts and molecular tools is essential for success.
- Advancements in expression and purification enhance the efficiency and safety of this technology.
Related Concept Videos
Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Plant Breeding and Biotechnology
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
The Phragmoplast
Cell division is essential for organismal growth and development. In animal cells, the central spindle and its associated proteins form the midbody, a structure that has an essential role in cytokinesis. In plants, the central spindle, along with the microtubules, actin, and other cell components, matures into the phragmoplast, which is necessary for cytokinesis. Unlike the stationary midbody, the phragmoplast expands centrifugally, eventually leading to the formation of the new cell wall.
The...
The...
Transgenic Organisms
Overview
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
